Native American populations declined between 1492 and 1900 CE, instigated by the European colonization of the Americas. However, the magnitude, tempo, and ecological effects of this depopulation remain the source of enduring debates. Recently, scholars have linked indigenous demographic decline, Neotropical reforestation, and shifting fire regimes to global changes in climate, atmosphere, and the Early Anthropocene hypothesis. In light of these studies, we assess these processes in conifer-dominated forests of the Southwest United States. We compare light detection and ranging data, archaeology, dendrochronology, and historical records from the Jemez Province of New Mexico to quantify population losses, establish dates of depopulation events, and determine the extent and timing of forest regrowth and fire regimes between 1492 and 1900. We present a new formula for the estimation of Pueblo population based on architectural remains and apply this formula to 18 archaeological sites in the Jemez Province. A dendrochronological study of remnant wood establishes dates of terminal occupation at these sites. By combining our results with historical records, we report a model of pre- and post-Columbian population dynamics in the Jemez Province. Our results indicate that the indigenous population of the Jemez Province declined by 87% following European colonization but that this reduction occurred nearly a century after initial contact. Depopulation also triggered an increase in the frequency of extensive surface fires between 1640 and 1900. Ultimately, this study illustrates the quality of integrated archaeological and paleoecological data needed to assess the links between Native American population decline and ecological change after European contact.
Acute bacterial infections are often treated empirically, with the choice of antibiotic therapy updated during treatment. The effects of such rapid antibiotic switching on the evolution of antibiotic resistance in individual patients are poorly understood. Here we find that low-frequency antibiotic resistance mutations emerge, contract, and even go to extinction within days of changes in therapy. We analyzed Pseudomonas aeruginosa populations in sputum samples collected serially from 7 mechanically ventilated patients at the onset of respiratory infection. Combining short- and long-read sequencing and resistance phenotyping of 420 isolates revealed that while new infections are near-clonal, reflecting a recent colonization bottleneck, resistance mutations could emerge at low frequencies within days of therapy. We then measured the in vivo frequencies of select resistance mutations in intact sputum samples with resistance-targeted deep amplicon sequencing (RETRA-Seq), which revealed that rare resistance mutations not detected by clinically used culture-based methods can increase by nearly 40-fold over 5–12 days in response to antibiotic changes. Conversely, mutations conferring resistance to antibiotics not administered diminish and even go to extinction. Our results underscore how therapy choice shapes the dynamics of low-frequency resistance mutations at short time scales, and the findings provide a possibility for driving resistance mutations to extinction during early stages of infection by designing patient-specific antibiotic cycling strategies informed by deep genomic surveillance.
Infections caused by members of the
Burkholderia cepacia
complex (BCC) are a serious concern for patients with cystic fibrosis (CF) as these bacteria are often resistant to many antibiotics. During long-term infection of CF patients with BCC, mutations in genes encoding the FixLJ system often become prevalent, suggesting that these changes may benefit the bacteria during infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.